Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
Bielesz
Bernhard
B
Abteilung Nephrologie und Dialyse, Medizinische Universität Wien, Wien, Austria. bernhard.bielesz@meduniwien.ac.at
D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000097:blood; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000188:drug therapy; D007677:Kidney Function Tests; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood*; D011379:Prognosis; D014807:Vitamin D / Q000627:therapeutic use
D015415:Biomarkers; D010281:Parathyroid Hormone; D010710:Phosphates; D014807:Vitamin D; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D002118:Calcium